December 24, 2025

FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer

December 24, 2025 / Clinical Practice / InnovateMed Author / lung cancer

by Lori Solomon edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). Rybrevant Faspro is approved across all indications of intravenously administered […]

FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer Read More »

Flu is hitting California early—doctors worry this year will be especially hard on kids

December 24, 2025 / Clinical Practice / InnovateMed Author / flu

by Rong-Gong Lin II edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes Credit: Andrea Piacquadio from Pexels Fueled by a new viral strain, flu is hitting California early—and doctors are warning that they expect the season may be particularly tough on young children. Concentrations of flu detected in wastewater have surged in the San Francisco

Flu is hitting California early—doctors worry this year will be especially hard on kids Read More »

Fathers’ microplastics exposure tied to their children’s metabolic problems

December 24, 2025 / Clinical Practice / InnovateMed Author / metabolic problem

by Iqbal Pittalwala, University of California – Riverside edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father’s exposure to microplastics (MPs) can trigger metabolic dysfunctions in his offspring. The research, conducted using

Fathers’ microplastics exposure tied to their children’s metabolic problems Read More »

Monoclonal antibody shows promising results for rare liver disease

December 24, 2025 / Research update / InnovateMed Author / liver disease

by Liam Connolly, UC Davis edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and anti-fibrotic monoclonal antibody known as

Monoclonal antibody shows promising results for rare liver disease Read More »

How age affects recovery from spinal cord injury

December 24, 2025 / Research update / InnovateMed Author / spinal cord injury

by American Academy of Neurology edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain A study published in Neurology looks at how age may affect recovery for people with spinal cord injuries. “With population growth and improvements in medicine, the number of people diagnosed with spinal cord injury is increasing and the average age at

How age affects recovery from spinal cord injury Read More »

The best gift ever’: Baby is born after the rarest of pregnancies, defying all odds

December 24, 2025 / Research update / InnovateMed Author / pregnancy

by Laura Ungar edited by Andrew Zinin Editors’ notes This photo provided by the family shows Suze Lopez, and her son, Ryu, in California in October 2025. Credit: Lopez family via AP Suze Lopez holds her baby boy on her lap and marvels at the remarkable way he came into the world. Before little Ryu was

The best gift ever’: Baby is born after the rarest of pregnancies, defying all odds Read More »

Can eating high fat cheese and cream reduce dementia risk, as a new study suggests?

December 24, 2025 / Research update / InnovateMed Author / dementia risk

by Eef Hogervorst, The Conversation edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Credit: CC0 Public Domain A large Swedish study reported a lower risk of dementia among middle-aged and older adults who consumed higher amounts of full-fat cheese and cream. The findings may sound like welcome news but they need careful interpretation. The study followed 27,670 participants

Can eating high fat cheese and cream reduce dementia risk, as a new study suggests? Read More »

AI-powered ‘glasses’ help the blind go places – safely

December 24, 2025 / Research update / InnovateMed Author / glasses

By Abhimanyu Ghoshal December 23, 2025 Facebook Twitter LinkedIn Reddit Flipboard Email The .Lumen glasses are more of a headset than spectacles, and this device delivers haptic feedback to your forehead to guide you around your surroundings .Lumen View 4 Images View gallery – 4 images An upcoming wearable device for the legally blind could help

AI-powered ‘glasses’ help the blind go places – safely Read More »

‘Stingraybot’ uses microbubble muscles controlled by ultrasound

December 24, 2025 / Research update / InnovateMed Author / Ultrasound

By Malcolm Azania December 23, 2025 Facebook Twitter LinkedIn Reddit Flipboard Email A multiple exposure of the microbubble-muscled stingraybot going for a swim Shi Z et al. Nature 2025 View 3 Images View gallery – 3 images While it might sound like a weapon of oceanic destruction in the hands of Aquaman’s arch enemies, the new

‘Stingraybot’ uses microbubble muscles controlled by ultrasound Read More »

Is Tirzepatide Easier on the Eyes Than GLP-1s?

December 24, 2025 / Clinical Practice / InnovateMed Author / GLP 1

Edited by Archita Rai December 10, 2025 TOPLINE: Patients with type 2 diabetes who used tirzepatide had a 50% lower risk of developing primary open-angle glaucoma, a 41% lower risk of developing elevated eye pressure, and a 46% lower risk of initiating glaucoma treatments than those who used GLP-1 receptor agonists. METHODOLOGY: Researchers conducted a retrospective cohort study to

Is Tirzepatide Easier on the Eyes Than GLP-1s? Read More »